XML 30 R20.htm IDEA: XBRL DOCUMENT v3.23.2
STOCK-BASED COMPENSATION PLANS
6 Months Ended
Jun. 30, 2023
STOCK-BASED COMPENSATION PLANS  
STOCK-BASED COMPENSATION PLANS

NOTE 12 – STOCK-BASED COMPENSATION PLANS

The Company has adopted the HBT Financial, Inc. Omnibus Incentive Plan (the “Omnibus Incentive Plan”). The Omnibus Incentive Plan provides for grants of (i) stock options, (ii) stock appreciation rights, (iii) restricted shares, (iv) restricted stock units, (v) performance awards, (vi) other share-based awards and (vi) other cash-based awards to eligible employees, non-employee directors and consultants of the Company. The maximum number of shares of common stock available for issuance under the Omnibus Incentive Plan is 1,820,000 shares.

The following is a summary of stock-based compensation expense (benefit):

Three Months Ended June 30, 

Six Months Ended June 30, 

    

2023

    

2022

    

2023

    

2022

    

(dollars in thousands)

Restricted stock units

$

317

$

234

$

594

$

842

Performance restricted stock units

117

118

357

411

Total awards classified as equity

434

352

951

1,253

Stock appreciation rights

(47)

7

(46)

(16)

Total stock-based compensation expense

$

387

$

359

$

905

$

1,237

In February 2022, all outstanding restricted stock unit and performance restricted stock unit agreements were modified to address treatment upon retirement. In the event of retirement, and if the retirement eligibility requirements are met, then 100% of unvested restricted stock units and performance restricted stock units will continue to vest in accordance with the originally established vesting schedule. The retirement modification resulted in the acceleration of $0.6 million of expense, although total compensation costs related to the modified agreements remained the same.

Restricted Stock Units

A restricted stock unit grants a participant the right to receive one share of the Company’s common stock, following the completion of the requisite service period. Restricted stock units are classified as equity. Compensation cost is based on the Company’s stock price on the grant date and is recognized on a straight-line basis over the service period for the entire award. Dividend equivalents on restricted stock units, which are either accrued until vested or paid at the same time as dividends on common stock, are classified as dividends charged to retained earnings.

During the six months ended June 30, 2023 and 2022, the total grant date fair value of the restricted stock units granted was $1.0 million and $0.9 million, respectively, based on the grant date closing prices. The total intrinsic value of restricted stock that vested during the six months ended June 30, 2023 and 2022 was $1.1 million and $0.7 million, respectively.

The following is a summary of restricted stock unit activity:

Three Months Ended June 30, 

2023

2022

Weighted

Weighted

Average

Average

Restricted

Grant Date

Restricted

Grant Date

    

Stock Units

    

Fair Value

    

Stock Units

    

Fair Value

Beginning balance

129,422

$

19.58

120,631

$

17.98

Granted

Vested

Forfeited

Ending balance

129,422

$

19.58

120,631

$

17.98

Six Months Ended June 30, 

2023

2022

Weighted

Weighted

Average

Average

Restricted

Grant Date

Restricted

Grant Date

    

Stock Units

    

Fair Value

    

Stock Units

    

Fair Value

Beginning balance

139,986

$

18.01

109,244

$

17.27

Granted

41,847

22.72

46,312

19.11

Vested

(51,693)

17.91

(34,925)

17.26

Forfeited

(718)

16.58

Ending balance

129,422

$

19.58

120,631

$

17.98

As of June 30, 2023, unrecognized compensation cost related to the non-vested restricted stock units was $1.6 million. This cost is expected to be recognized over the weighted average remaining service period of 1.8 years.

Performance Restricted Stock Units

A performance restricted stock unit is similar to a restricted stock unit, except that the number of shares of the Company’s common stock awarded is based on a performance condition and the completion of the requisite service period. The number of shares of the Company’s common stock that may be earned ranges from 0% to 150% of the number of performance restricted stock units granted. Performance restricted stock units are classified as equity. Compensation cost is based on the Company’s stock price on the grant date and an assessment of the probable outcome of the performance condition. Compensation cost is recognized on a straight-line basis over the service period of the entire award. Changes in the performance condition probability assessment result in cumulative catch-up adjustments to the compensation cost recognized. Dividend equivalents on performance restricted stock units, which are accrued until vested, are classified as dividends charged to retained earnings.

During the six months ended June 30, 2023 and 2022, the total fair value of the performance restricted stock units granted was $0.4 million and $0.5 million, respectively, based on the grant date closing prices and an assessment of the probable outcome of the performance condition on the grant date.

The following is a summary of performance restricted stock unit activity:

Three Months Ended June 30, 

2023

2022

Weighted

Weighted

Performance

Average

Performance

Average

Restricted

Grant Date

Restricted

Grant Date

    

Stock Units

    

Fair Value

    

Stock Units

    

Fair Value

Beginning balance

79,097

$

18.25

62,067

$

17.02

Granted

Vested

Forfeited

Ending balance

79,097

$

18.25

62,067

$

17.02

Six months ended June 30, 

2023

2022

Weighted

Weighted

Performance

Average

Performance

Average

Restricted

Grant Date

Restricted

Grant Date

    

Stock Units

    

Fair Value

    

Stock Units

    

Fair Value

Beginning balance

62,067

$

17.02

38,344

$

15.72

Granted

17,030

22.72

23,723

19.14

Vested

Forfeited

Ending balance

79,097

$

18.25

62,067

$

17.02

As of June 30, 2023, unrecognized compensation cost related to non-vested performance restricted stock units was $0.5 million, based on the current assessment of the probable outcome of the performance conditions. This cost is expected to be recognized over the weighted average remaining service period of 1.7 years.

Stock Appreciation Rights

A stock appreciation right grants a participant the right to receive an amount of cash, the value of which equals the appreciation in the Company’s stock price between the grant date and the exercise date. Stock appreciation rights are classified as liabilities. The liability is based on an option-pricing model used to estimate the fair value of the stock appreciation rights. Compensation cost for non-vested stock appreciation rights is recognized on a straight line basis over the service period of the entire award. The non-vested stock appreciation rights vest in four equal annual installments beginning on the first anniversary of the grant date.

The following is a summary of stock appreciation rights activity:

Three Months Ended June 30, 

2023

2022

    

Stock
Appreciation
Rights
Outstanding

    

Weighted
Average
Grant Date
Assigned Value

    

Stock
Appreciation
Rights
Outstanding

    

Weighted
Average
Grant Date
Assigned Value

Beginning balance

73,440

$

16.32

91,800

$

16.32

Granted

Exercised

Expired

Forfeited

Ending balance

73,440

$

16.32

91,800

$

16.32

Six Months Ended June 30, 

2023

2022

    

Stock
Appreciation
Rights

    

Weighted
Average
Grant Date
Assigned Value

    

Stock
Appreciation
Rights

    

Weighted
Average
Grant Date
Assigned Value

Beginning balance

73,440

$

16.32

97,920

$

16.32

Granted

Exercised

(6,120)

16.32

Expired

Forfeited

Ending balance

73,440

$

16.32

91,800

$

16.32

A further summary of stock appreciation rights as of June 30, 2023, is as follows:

Weighted Average

Stock Appreciation Rights

Remaining

Grant Date Assigned Values

    

Outstanding

    

Exercisable

    

Contractual Term

$ 16.32

73,440

67,320

6.2

years

As of June 30, 2023, unrecognized compensation cost related to non-vested stock appreciation rights was $6 thousand.

As of June 30, 2023 and December 31, 2022, the liability recorded for outstanding stock appreciation rights was $0.4 million and $0.5 million, respectively. The Company used an option pricing model to value the stock appreciation rights, using the assumptions in the following table. Expected volatility is derived from the historical volatility of the Company’s stock price and a selected peer group of industry-related companies.

    

June 30, 2023

    

December 31, 2022

Risk-free interest rate

4.06

%

3.95

%

Expected volatility

37.35

%

36.54

%

Expected life (in years)

6.2

6.7

Expected dividend yield

3.69

%

3.27

%

As of June 30, 2023, the liability recorded for previously exercised stock appreciation rights was $0.2 million, which will be paid in one remaining annual installment in 2024. As of December 31, 2022, the liability recorded for previously exercised stock appreciation rights was $0.5 million.